"We achieved a number of financial milestones in the first quarter of
2008, including our 10th consecutive quarter of revenue growth, our sixth
consecutive quarter of profitability and our fifth consecutive quarter of
positive cash flow from operations," Davin said. "Even in a challenging
macroeconomic environment, we have delivered outstanding results based on
our unwavering commitment to having the best technology, products and
distribution in the industry. Looking ahead, we believe our customers
remain positive about their purchasing intentions and consumer sentiment."
-- Cynosure introduced Smartlipo MPX(TM) (MultiPlex), the first
FDA-cleared dual-wavelength system for laser lipolysis. The new
workstation incorporates both a 1064-nm and a 1320-nm wavelength to
remove unwanted pockets of fat and tighten the surrounding tissue with
optimal results. The company plans to introduce Smartlipo MPX in the
United States beginning in the second quarter of 2008 and
internationally in the second half of this year.
-- The company's aesthetic laser technology was featured in five
presentations by some of the industry's leading experts at the 28th
American Society for Laser Medicine and Surgery (ASLMS) Annual
Conference. The data presented at ASLMS provided further support for
the clinical benefits of Cynosure's technology for some of the
|SOURCE Cynosure, Inc.|
Copyright©2008 PR Newswire.
All rights reserved